Paul Abel

2.0k total citations
62 papers, 1.6k citations indexed

About

Paul Abel is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Paul Abel has authored 62 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 14 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Paul Abel's work include Prostate Cancer Treatment and Research (27 papers), Hormonal and reproductive studies (13 papers) and Prostate Cancer Diagnosis and Treatment (9 papers). Paul Abel is often cited by papers focused on Prostate Cancer Treatment and Research (27 papers), Hormonal and reproductive studies (13 papers) and Prostate Cancer Diagnosis and Treatment (9 papers). Paul Abel collaborates with scholars based in United Kingdom, United States and Greece. Paul Abel's co-authors include El–Nasir Lalani, Christopher S. Foster, Qilong Lu, Gordon Stamp, Kenneth Gannon, Lesley Glover, Soha El Sheikh, Jan Domin, Marc Laniado and Markos Karavitakis and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer.

In The Last Decade

Paul Abel

59 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul Abel United Kingdom	24	531	486	340	220	200	62	1.6k
P D Abel United Kingdom	22	416 0.8×	598 1.2×	261 0.8×	190 0.9×	503 2.5×	54	1.7k
Julie Blatt United States	32	326 0.6×	757 1.6×	797 2.3×	221 1.0×	686 3.4×	142	3.5k
Nina Ditsch Germany	24	204 0.4×	513 1.1×	555 1.6×	485 2.2×	141 0.7×	116	1.8k
Maysa Al‐Hussaini Jordan	21	369 0.7×	395 0.8×	363 1.1×	82 0.4×	227 1.1×	173	1.9k
Kristina Hotakainen Finland	19	152 0.3×	424 0.9×	185 0.5×	170 0.8×	232 1.2×	38	1.2k
C. Sue Richards United States	20	394 0.7×	934 1.9×	434 1.3×	913 4.2×	180 0.9×	41	2.3k
David R. Genest United States	36	219 0.4×	665 1.4×	153 0.5×	422 1.9×	548 2.7×	92	3.5k
Hongbo Yang United States	24	256 0.5×	326 0.7×	443 1.3×	110 0.5×	143 0.7×	136	1.9k
Johnathan Watkins United Kingdom	19	319 0.6×	835 1.7×	684 2.0×	201 0.9×	289 1.4×	31	2.7k
Carmen Martínez‐García Spain	27	232 0.4×	431 0.9×	513 1.5×	136 0.6×	189 0.9×	62	2.0k

Countries citing papers authored by Paul Abel

Since Specialization

Citations

This map shows the geographic impact of Paul Abel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Abel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Abel more than expected).

Fields of papers citing papers by Paul Abel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Abel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Abel. The network helps show where Paul Abel may publish in the future.

Co-authorship network of co-authors of Paul Abel

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Abel. A scholar is included among the top collaborators of Paul Abel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Abel. Paul Abel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shah, Syed Imran Ali, et al.. (2017). Cardiovascular toxicities of systemic treatments of prostate cancer: oestrogen to the rescue?. Nature Reviews Urology. 14(9). 575–575. 1 indexed citations

Shah, Syed Imran Ali, Paul Abel, Patricia M. Price, et al.. (2015). Contemporary hormone therapy with LHRH agonists for prostate cancer: avoiding osteoporosis and fracture. Editor-in-Chief s Voice List of Authors is an Important Element in a Scientific Publication. 68(2). 165–8. 6 indexed citations

Shah, Syed Imran Ali, et al.. (2014). Androgen Deprivation Therapy and the Re-emergence of Parenteral Estrogen in Prostate Cancer. PubMed. 10(1). 42–42. 12 indexed citations

Gale‐Grant, Oliver, et al.. (2013). Developing ideas of professionalism. The Clinical Teacher. 10(3). 165–169. 17 indexed citations

Karavitakis, Markos, Hashim U. Ahmed, Paul Abel, et al.. (2012). Trends in pathologic outcomes after introduction of active surveillance in the UK: Implication for focal therapy. The Prostate. 72(13). 1464–1468. 5 indexed citations

Gauthier, Thomas, et al.. (2012). Reproducibility of Quantitative Assessment of Altered Hepatic Hemodynamics With Dynamic Contrast-Enhanced Ultrasound. Journal of Ultrasound in Medicine. 31(9). 1413–1420. 9 indexed citations

Karavitakis, Markos, Hashim U. Ahmed, Paul Abel, Steven Hazell, & Mathias Winkler. (2011). Margin Status After Laparoscopic Radical Prostatectomy and the Index Lesion: Implications for Preoperative Evaluation of Tumor Focality in Prostate Cancer. Journal of Endourology. 26(5). 503–508. 21 indexed citations

Mukerji, Gaurav, et al.. (2010). A COMMUNITY UROLOGY SERVICE: FACT OR FICTION?. British Journal of Urology. 106(10). 1428–1430. 2 indexed citations

Pope, A. & Paul Abel. (2010). Androgen deprivation therapy for prostate cancer and its complications. 15(3). 32–37. 1 indexed citations

10.

Ockrim, Jeremy, et al.. (2006). Changes in vascular flow after transdermal oestradiol therapy for prostate cancer: a mechanism for cardiovascular toxicity and benefit?. British Journal of Urology. 97(3). 498–504. 8 indexed citations

11.

Romańska, Hanna, et al.. (2004). TFF2 (trefoil family factor2) inhibits apoptosis in breast and colorectal cancer cell lines. Peptides. 25(5). 855–863. 25 indexed citations

12.

Sheikh, Soha El, Jan Domin, Paul Abel, Gordon Stamp, & El–Nasir Lalani. (2004). Phosphorylation of Both EGFR and ErbB2 Is a Reliable Predictor of Prostate Cancer Cell Proliferation in Response to EGF. Neoplasia. 6(6). 846–853. 76 indexed citations

13.

Romańska, Hanna, Paul Abel, Tuncay Kayademir, et al.. (2004). TFF1 is membrane-associated in breast carcinoma cell line MCF-7. Peptides. 25(5). 745–753. 2 indexed citations

14.

Sheikh, Soha El, et al.. (2003). Topographical expression of class IA and class II Phosphoinositide 3-kinase Enzymes in normal human tissues is consistent with a role in differentiation. 3(4). 2 indexed citations

15.

Sheikh, Soha El, et al.. (2003). Topographical expression of class IA and class II phosphoinositide 3-kinase enzymes in normal human tissues is consistent with a role in differentiation. BMC Clinical Pathology. 3(1). 4–4. 34 indexed citations

16.

Kraus, Sigurd, Paul Abel, W. Weidner, et al.. (2002). MUC1 mucin and trefoil factor 1 protein expression in renal cell carcinoma: Correlation with prognosis. Human Pathology. 33(1). 60–67. 47 indexed citations

17.

Black, Nicholas, et al.. (1998). What Determines the Choice of Procedure in Stress Incontinence Surgery?: The Use of Multilevel Modeling. International Journal of Technology Assessment in Health Care. 14(3). 431–445. 11 indexed citations

18.

Lü, Qi, El–Nasir Lalani, & Paul Abel. (1997). Human Papillomavirus 16 and 18 Infection Is Absent in Urinary Bladder Carcinomas. European Urology. 31(4). 428–432. 18 indexed citations

19.

Lu, Qilong, Paul Abel, Christopher S. Foster, & El–Nasir Lalani. (1996). bcl-2: Role in epithelial differentiation and oncogenesis. Human Pathology. 27(2). 102–110. 236 indexed citations

20.

Breed, Michael D., et al.. (1990). Thievery, home ranges, and nestmate recognition inEctatomma ruidum. Oecologia. 84(1). 117–121. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact